According to the new research report published by Premium Market Insights, title "Cerebrospinal Fluid Management Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Neurological Centers)," the market is expected to grow from US$ 1.82 billion in 2021 to US$ 2.61 billion by 2028; it is estimated to grow at a CAGR of 5.3% from 2021 to 2028. The report highlights the key factors driving and restraining the market growth, trends prevailing in the market, and prominent players with their developments.

Market Overview

Cerebrospinal fluid (CSF) management involves the use of devices such as shunts and external drainage systems to maintain the flow of CSF and remove excess fluid from the brain to prevent irreversible injury to the central nervous system caused by increased intracranial pressure. The cerebrospinal fluid serves several functions, including protection against sudden changes in venous and arterial blood pressure or impact pressure. The global market is being driven by the high prevalence of hydrocephalus and the subsequent increase in shunting procedures. However, the lack of skilled professionals in developing economies and complications related to CSF shunt malfunctions are expected to impede overall market growth. 

Market Segmentation

The cerebrospinal fluid management market is categorized by end user into hospitals, clinics, ambulatory surgical centers, and neurological centers, with hospitals holding the largest market share in 2021. The hospitals segment held the largest market share of the global cerebrospinal fluid management market because hospitals are the primary healthcare facilities where patients with various neurological disorders are diagnosed and treated, and cerebrospinal fluid management is a critical part of their treatment. In addition, hospitals typically have more resources and advanced medical equipment required for cerebrospinal fluid management procedures, which may not be available in smaller clinics or ambulatory surgical centers. This makes hospitals a key end-user in the cerebrospinal fluid management market. However, the neurological center segment is expected to exhibit the highest CAGR during the forecast period. This is attributed to the fact that neurological centers are now using endoscopic third ventriculostomy (ETV) as an alternative to shunt replacement for the treatment of hydrocephalus.  Geographically, the cerebrospinal fluid management market is segmented into North America (including the US, Canada, and Mexico), Europe (including the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (including China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (including the UAE, Saudi Arabia, Africa, and the Rest of Middle East & Africa), and South and Central America (including Brazil, Argentina, and the Rest of South and Central America).

Get PDF Sample at @ https://www.premiummarketinsights.com/sample/TIP00012585/

Impact of COVID-19

The COVID-19 pandemic has had a profound impact, with neurological patients being among the most severely affected groups. The pandemic has significantly affected the diagnosis and treatment of tumors. Due to the increasing hospitalization rate of COVID-19 patients, many hospitals & departments, including neurology clinics, had to be repurposed to treat COVID-19 patients, creating added pressure. Despite this, the cerebrospinal fluid management market in Asia-Pacific is expected to grow the most rapidly during the forecast period, with China and India being the main drivers of this growth. This is attributed to the rising incidence of CSF leaks and increasing advancements in CSF management products.

Market Players

The cerebrospinal fluid management market is dominated by top companies including Medtronic plc, Integra LifeSciences Corporation, B. Braun Melsungen AG, Depuy Synthes, Sophysa SA, BeckerSmith Medical, Biometri, Spiegelberg GmbH & Co, Moller Medical GmbH, and Dispomedica GmbH.

Read More @ https://www.premiummarketinsights.com/reports-tip/cerebrospinal-fluid-management-market/

About Us:

Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.

The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.

Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.

We provide best in classcustomer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.co